Diagnostic or Therapeutic Strategies for Pregnancy Complications
Funding
Conflicts of Interest
References
- Inkster, A.M.; Fernández-Boyano, I.; Robinson, W.P. Sex differences are here to stay: Relevance to prenatal care. J. Clin. Med. 2021, 10, 3000. [Google Scholar] [CrossRef] [PubMed]
- Park, H.S.; Kwon, H.; Kwon, J.-Y.; Jung, Y.J.; Seol, H.-J.; Seong, W.J.; Kim, H.M.; Hwang, H.-S.; Sung, J.-H.; Oh, S.-Y. Uterine cervical change at term examined using ultrasound elastography: A longitudinal study. J. Clin. Med. 2020, 10, 75. [Google Scholar] [CrossRef] [PubMed]
- Benton, S.J.; Mery, E.E.; Grynspan, D.; Gaudet, L.M.; Smith, G.N.; Bainbridge, S.A. Placental pathology as a tool to identify women for postpartum cardiovascular risk screening following preeclampsia: A preliminary investigation. J. Clin. Med. 2022, 11, 1576. [Google Scholar] [CrossRef] [PubMed]
- Mavedatnia, D.; Tran, J.; Oltean, I.; Bijelić, V.; Moretti, F.; Lawrence, S.; El Demellawy, D. Impact of co-existing placental pathologies in pregnancies complicated by placental abruption and acute neonatal outcomes. J. Clin. Med. 2021, 10, 5693. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.H.; Park, C.-W.; Moon, K.C.; Park, J.S.; Jun, J.K. The inflammatory milieu of amniotic fluid increases with chorio-deciduitis grade in inflammation-restricted to choriodecidua, but not amnionitis, of extra-placental membranes. J. Clin. Med. 2021, 10, 3041. [Google Scholar] [CrossRef] [PubMed]
- Bujold, E.; Fillion, A.; Roux-Dalvai, F.; Scott-Boyer, M.P.; Giguère, Y.; Forest, J.-C.; Gotti, C.; Laforest, G.; Guerby, P.; Droit, A. Proteomic analysis of maternal urine for the early detection of preeclampsia and fetal growth restriction. J. Clin. Med. 2021, 10, 4679. [Google Scholar] [CrossRef] [PubMed]
- Burchard, J.; Polpitiya, A.D.; Fox, A.C.; Randolph, T.L.; Fleischer, T.C.; Dufford, M.T.; Garite, T.J.; Critchfield, G.C.; Boniface, J.J.; Saade, G.R.; et al. Clinical validation of a proteomic biomarker threshold for increased risk of spontaneous preterm birth and associated clinical outcomes: A replication study. J. Clin. Med. 2021, 10, 5088. [Google Scholar] [CrossRef] [PubMed]
- Wyatt, M.A.; Baumgarten, S.C.; Weaver, A.L.; Van Oort, C.C.; Fedyshyn, B.; Ruano, R.; Shenoy, C.C.; Enninga, E.A.L. Evaluating markers of immune tolerance and angiogenesis in maternal blood for an association with risk of pregnancy loss. J. Clin. Med. 2021, 10, 3579. [Google Scholar] [CrossRef] [PubMed]
- Gannoun, M.B.A.; Raguema, N.; Zitouni, H.; Mehdi, M.; Seda, O.; Mahjoub, T.; Lavoie, J. MMP-2 and MMP-9 polymorphisms and preeclampsia risk in Tunisian Arabs: A case-control study. J. Clin. Med. 2021, 10, 2647. [Google Scholar] [CrossRef] [PubMed]
- Kniotek, M.; Roszczyk, A.; Zych, M.; Wrzosek, M.; Szafarowska, M.; Zagożdżon, R.; Jerzak, M. Sildenafil citrate downregulates PDE5A mRNA expression in women with recurrent pregnancy loss without altering angiogenic factors—A preliminary study. J. Clin. Med. 2021, 10, 5086. [Google Scholar] [CrossRef] [PubMed]
- Murphy, C.N.; Cluver, C.A.; Walker, S.P.; Keenan, E.; Hastie, R.; MacDonald, T.M.; Hannan, N.J.; Brownfoot, F.C.; Cannon, P.; Tong, S.; et al. Circulating SPINT1 is reduced in a preeclamptic cohort with co-existing fetal growth restriction. J. Clin. Med. 2022, 11, 901. [Google Scholar] [CrossRef] [PubMed]
- Binder, N.K.; MacDonald, T.M.; Beard, S.A.; de Alwis, N.; Tong, S.; Kaitu’U-Lino, T.; Hannan, N. Pre-clinical investigation of cardioprotective beta-blockers as a therapeutic strategy for preeclampsia. J. Clin. Med. 2021, 10, 3384. [Google Scholar] [CrossRef] [PubMed]
- Brien, M.-E.; Gaudreault, V.; Hughes, K.; Hayes, D.J.L.; Heazell, A.E.P.; Girard, S. A systematic review of the safety of blocking the IL-1 system in human pregnancy. J. Clin. Med. 2021, 11, 225. [Google Scholar] [CrossRef] [PubMed]
- Coler, B.S.; Shynlova, O.; Boros-Rausch, A.; Lye, S.; McCartney, S.; Leimert, K.; Xu, W.; Chemtob, S.; Olson, D.; Li, M.; et al. Landscape of preterm birth therapeutics and a path forward. J. Clin. Med. 2021, 10, 2912. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Couture, C.; Girard, S. Diagnostic or Therapeutic Strategies for Pregnancy Complications. J. Clin. Med. 2022, 11, 3144. https://doi.org/10.3390/jcm11113144
Couture C, Girard S. Diagnostic or Therapeutic Strategies for Pregnancy Complications. Journal of Clinical Medicine. 2022; 11(11):3144. https://doi.org/10.3390/jcm11113144
Chicago/Turabian StyleCouture, Camille, and Sylvie Girard. 2022. "Diagnostic or Therapeutic Strategies for Pregnancy Complications" Journal of Clinical Medicine 11, no. 11: 3144. https://doi.org/10.3390/jcm11113144